SYNGAP1 and epilepsy: Quad GS with an unaffected sibling revealed a de novo, exonic, pathogenic variant (c.3415insA, p.T1140DfsX13) in SYNGAP1 (MIM# 603384), resulting in a certain diagnosis of Intellectual disability, AD 5 (MIM# 612621), which also includes epilepsy.